Experimental Pharmacological Agents for the Treatment of Primary Biliary Cholangitis

The standard therapy for primary biliary cholangitis (PBC) is ursodeoxycholic acid (UDCA) which has shown to improve hepatic biochemistry, delay histological progression and improve transplant-free survival. Approximately 30–40% of patients do not respond or are intolerant to UDCA. Obeticholic acid,...

Descripción completa

Detalles Bibliográficos
Autor principal: Floreani, Annarosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751712/
https://www.ncbi.nlm.nih.gov/pubmed/33364858
http://dx.doi.org/10.2147/JEP.S267375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751712/
https://www.ncbi.nlm.nih.gov/pubmed/33364858
http://dx.doi.org/10.2147/JEP.S267375

Ejemplares similares